HIGHLIGHTS
- What: The authors aimed to identify specific NMRGs to develop a prognostic model for predicting outcomes in patients with BC. The research provides evidence that SLC27A2 plays an important role in BC development, making it a potential target in BC therapy. The research investigated the potential prognosis biomarkers of BC, establishing a BC nucleotide metabolism signature. Although the research has identified a correlation between nucleotide metabolism-related molecules and the prognosis of BC for the first time, there are still some limitations to this study.
- Who: Bo Zhang from the Department of Thyroid, Breast and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.